Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Mann

Showing results (181-190 of 254) with videos related to

Pageof 26
Sort By:
Addiction (Abingdon, England)|February 23, 2021
Reward drinking and naltrexone treatment response among young adult heavy drinkersCorey R Roos, Krysten W Bold, Katie Witkiewitz, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 23, 2004
Challenges to medications development in treating alcohol dependence: an international perspectiveJohn M Littleton, Philippe De Witte, Raye Litten, et al.
The European Journal of Neuroscience|August 3, 2006
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuliThomas Siessmeier, Thorsten Kienast, Jana Wrase, et al.
Archives of General Psychiatry|January 5, 2005
Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanilAndreas Heinz, Matthias Reimold, Jana Wrase, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 19, 2008
Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuliThorsten Kienast, Thomas Siessmeier, Jana Wrase, et al.
Addiction Biology|December 13, 2012
Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE studyKarl Mann, Tagrid Lemenager, Sabine Hoffmann, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 12, 2024
Reductions in World Health Organization risk drinking level are associated with improvements in sleep problems among individuals with alcohol use disorderChristian C Garcia, Dylan K Richards, Felicia R Tuchman, et al.
Biological Psychiatry|September 13, 2011
Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and ratsDerik Hermann, Wolfgang Weber-Fahr, Alexander Sartorius, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2016
Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain AnalysisDerik Hermann, Natalie Hirth, Matthias Reimold, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2011
The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disordersRaymond F Anton, Raye Z Litten, Daniel E Falk, et al.
Pageof 26

Showing results (181-190 of 254) with videos related to

Sort By:
Pageof 26
Addiction (Abingdon, England)|February 23, 2021
Reward drinking and naltrexone treatment response among young adult heavy drinkersCorey R Roos, Krysten W Bold, Katie Witkiewitz, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 23, 2004
Challenges to medications development in treating alcohol dependence: an international perspectiveJohn M Littleton, Philippe De Witte, Raye Litten, et al.
The European Journal of Neuroscience|August 3, 2006
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuliThomas Siessmeier, Thorsten Kienast, Jana Wrase, et al.
Archives of General Psychiatry|January 5, 2005
Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanilAndreas Heinz, Matthias Reimold, Jana Wrase, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 19, 2008
Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuliThorsten Kienast, Thomas Siessmeier, Jana Wrase, et al.
Addiction Biology|December 13, 2012
Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE studyKarl Mann, Tagrid Lemenager, Sabine Hoffmann, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 12, 2024
Reductions in World Health Organization risk drinking level are associated with improvements in sleep problems among individuals with alcohol use disorderChristian C Garcia, Dylan K Richards, Felicia R Tuchman, et al.
Biological Psychiatry|September 13, 2011
Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and ratsDerik Hermann, Wolfgang Weber-Fahr, Alexander Sartorius, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 12, 2016
Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain AnalysisDerik Hermann, Natalie Hirth, Matthias Reimold, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2011
The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disordersRaymond F Anton, Raye Z Litten, Daniel E Falk, et al.
Pageof 26